Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.

× No keyword cloud information.

11 in total

Review 1. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors: Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal: Acta Pharmacol Sin Date: 2015-04-20 Impact factor: 6.150

2. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

Authors: Ezgi Karaesmen; Abbas A Rizvi; Leah M Preus; Philip L McCarthy; Marcelo C Pasquini; Kenan Onel; Xiaochun Zhu; Stephen Spellman; Christopher A Haiman; Daniel O Stram; Loreall Pooler; Xin Sheng; Qianqian Zhu; Li Yan; Qian Liu; Qiang Hu; Amy Webb; Guy Brock; Alyssa I Clay-Gilmour; Sebastiano Battaglia; David Tritchler; Song Liu; Theresa Hahn; Lara E Sucheston-Campbell
Journal: Blood Date: 2017-08-15 Impact factor: 22.113

Review 3. The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.

Authors: N A Helsby; M Yong; M van Kan; J R de Zoysa; K E Burns
Journal: Br J Clin Pharmacol Date: 2019-07-22 Impact factor: 4.335

4. Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.

Authors: Veronika Bachanova; Ryan Shanley; Farhana Malik; Lata Chauhan; Vishal Lamba; Daniel J Weisdorf; Linda J Burns; Jatinder Kaur Lamba
Journal: Biol Blood Marrow Transplant Date: 2015-02-10 Impact factor: 5.742

5. Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.

Authors: E Snarski; A Milczarczyk; K Hałaburda; T Torosian; M Paluszewska; E Urbanowska; M Król; P Boguradzki; K Jedynasty; E Franek; W Wiktor-Jedrzejczak
Journal: Bone Marrow Transplant Date: 2015-12-07 Impact factor: 5.483

6. Managed Care, Hospital Characteristics, and Inpatient Utilization for Sickle Cell Disease Patients.

Authors: Eugene Lewit; Kavita Thirumalai; C Jason Wang
Journal: J Gen Intern Med Date: 2018-12 Impact factor: 6.473

Review 7. Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Authors: Lara E Sucheston-Campbell; Alyssa Clay; Philip L McCarthy; Qianqian Zhu; Leah Preus; Marcelo Pasquini; Kenan Onel; Theresa Hahn
Journal: Curr Hematol Malig Rep Date: 2015-03 Impact factor: 3.952

Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.